Xenon to present phase 3 azetukalner data at European Epilepsy Congress

August 26, 2026 4:01 PM

Xenon Pharmaceuticals Inc. (Nasdaq: XENE) plans to present six data sets at the 16th European Epilepsy Congress (EEC), scheduled for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found